Merck KGaA (OTCMKTS:MKGAF) Shares Gap Down – Should You Sell?

Shares of Merck KGaA (OTCMKTS:MKGAF) gapped down before the market opened on Tuesday . The stock had previously closed at $166.6010, but opened at $153.48. Merck KGaA shares last traded at $154.00, with a volume of 50 shares.

Merck KGaA Stock Performance

The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The firm’s fifty day moving average price is $163.43 and its 200-day moving average price is $149.49. The firm has a market cap of $21.08 billion, a price-to-earnings ratio of 24.90 and a beta of 0.96.

Hedge Funds Weigh In On Merck KGaA

Hedge funds have recently made changes to their positions in the company. Elefante Mark B acquired a new stake in shares of Merck KGaA during the second quarter worth about $617,000. Ames National Corp acquired a new stake in shares of Merck KGaA in the 2nd quarter valued at about $1,009,000. Notis McConarty Edward acquired a new stake in shares of Merck KGaA in the 2nd quarter valued at about $1,304,000. North Star Asset Management Inc. acquired a new stake in shares of Merck KGaA in the 2nd quarter valued at about $1,411,000. Finally, Pinnacle Holdings LLC purchased a new position in Merck KGaA during the 2nd quarter worth approximately $1,487,000. Hedge funds and other institutional investors own 0.10% of the company’s stock.

About Merck KGaA

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses.